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This case report describes two pediatric cases of immediate oxygen desaturation from 
methemoglobinemia and sulfhemoglobinemia after one sip from a plastic water bottle containing 
hydroxylamine sulfate used by a relative to clean shoes. Supplemental oxygen and two separate 
doses of methylene blue given to one of the patients had no effect on clinical symptoms or pulse 
oximetry. The patients were admitted to the pediatric Intensive Care Unit (ICU) with subsequent 
improvement after exchange transfusion. Endoscopy showed ulcer formation in one case and 
sucralafate was initiated; both patients were discharged after a one-week hospital stay. 
[WestJEM. 2009;10:197-201.]
INTRODUCTION
Sulfhemoglobinemia is a rare condition that can 
result from exposure to any substance containing a sulfur 
atom with the ability to bind to hemoglobin. Cases of 
sulfhemoglobinemia have been reported from ingestions of 
phenacetin, dapsone, and sulfonamides.1-3 Sulfhemoglobinemia 
should be considered in cases presenting with oxygen 
desaturation and cyanosis, especially if methemoglobinemia 
can be excluded. Unlike methemoglobinemia, which 
is reversible with a known antidote, methylene blue, 
sulfhemoglobinemia is irreversible with no known antidote. It 
requires early recognition, diagnosis and intervention in order 
to prevent end-organ damage, especially with high levels of 
sulfhemoglobin. The irreversibility of sulfhemoglobinemia 
illustrates the importance of its consideration as a diagnosis in 
the emergency department (ED).3 Using PubMed and Medline 
search engines from the National Library of Medicine, as 
well as the MD Consult website, we conducted a review of 
all-language medical literature from January 1966 to August 
2008 using the search parameters “Sulfhemoglobinemia 
and/or Methemoglobinemia and Hydroxylamine Sulfate.” 
The search resulted in zero articles. We also searched using 
Medical Subject Headings (MeSH) terms “pediatrics” and 
“sulfhemoglobinemia.” This generated a list of one article, 
a review.4 Finally, we reviewed the bibliography of the 
review found in the Medline search and looked for any 
obvious omissions from our literature review. Based on 
our literature review, we believe this to be the first report 
of pediatric patients developing methemoglobinemia and 
sulfhemoglobinemia from the ingestion of hydroxylamine 
sulfate.
CASE 1
A three-year-old male was brought by paramedics to the 
ED accompanied by his mother. She stated he had immediate 
blue-gray discoloration of skin, increased somnolence and 
abdominal pain after drinking one sip from a water bottle 
found in his sister’s room. The bottle, brought in by the 
paramedics, was noted to contain a colorless fluid. The 
patient’s mother denied knowledge of any substance mixed 
with the water and any toxic substances or drugs in the home. 
After the three-year-old drank from the bottle, he 
then gave it to his two-year-old cousin whose findings are 
discussed below. On history, the three-year-old boy pointed 
to his epigastrium for the location of the abdominal pain. 
He stated that the severity was “a little” and the quality was 
“sharp.” There was no vomiting, diarrhea, cough, change in 
behavior, or loss of consciousness. The patient was not taking Volume X, n o . 3  :  August 2009                                                   198                                      Western Journal of Emergency Medicine
medications, and past medical and family histories were 
unremarkable.
The physical exam showed an oral temperature of 36.4 
degrees Celsius, heart rate of 120 beats/minute, respiratory 
rate of 30 breaths/min, blood pressure of 115/43 mmHg, and 
oxygen saturation on room air of 84% by pulse oximetry. The 
patient weighed 18.5 kg. He demonstrated central cyanosis. 
Otherwise, his general appearance was of an alert and oriented 
male in no apparent distress. He was not diaphoretic, his 
mucous membranes were moist, his bowel sounds were 
normal, and his neurologic exam was normal. 
An arterial blood gas (ABG) while the patient was on 
100% oxygen via non-rebreather face mask showed a pH of 
7.53 (reference range 7.35-7.42), pCO2 of 25.2 mmHg (36-
50), pO2 of 249 mmHg (80-100), and HCO3 21.2 mmol/L 
(24-29). His calculated oxygen saturation on arterial blood 
gas (ABG) was 100%, whereas the finger pulse oximeter 
showed 84% oxygen saturation. Laboratory studies included a 
complete metabolic panel and complete blood count (Table).
Ethanol level was less than 10 mg/dL. A midstream clean-
catch urinalysis was normal, and a rapid urine drug screen was 
negative for amphetamines, barbiturates, benzodiazepines, 
opiates, cocaines, phencyclidines, and cannabanoids. The 
carboxyhemoglobin, methemoglobin and sulfhemoglobin 
levels had to be sent to an outside hospital lab. A chest 
radiograph showed no evidence of acute disease.
The three-year-old patient was placed on 100% 
supplemental oxygen and cardiac monitor, which showed 
normal sinus rhythm. An intravenous line (IV) was placed. 
The social worker attempted to locate the patient’s sister 
who had the bottle in her room. The Poison Control Center 
recommended giving a dose of methylene blue at a dose of 
1mg/kg. Methylene blue had no effect. At that time the blood 
specimen originally sent for analysis of the methemoglobin 
level was noted to be hemolyzed, and a second specimen was 
sent to the lab. A second dose of methylene blue at 1mg/kg 
was administered without effect. 
The patient’s older sister, who then arrived at the ED, 
stated that she had put a substance to clean shoes into the 
water bottle. It was “HAS”: hydroxylamine sulfate. At the 
same time the patient’s carboxyhemoglobin level returned 
from the lab at 0.6% (0%-5%) and methemoglobin level was 
5.4% (0.4%-1.5%). He was admitted to the pediatric ICU. 
The Gastroenterology service performed endoscopy on 
the patient due to continued abdominal pain. Endoscopy 
revealed two 1.5 cm by 1.5 cm Grade II ulcers (through the 
mucosa and muscularis mucosa) in the upper esophagus and 
multiple small, superficial erosions in the mid-esophagus, 
none of which were circumferential. The patient was started 
on sucralafate and ranitidine. 
The patient’s methemoglobin levels improved gradually 
after admission, dropping to 4.5% after the two doses of 
methylene blue described above. At 24 hours the level was 
3.1%, and by 36 hours post-ingestion hismethemoglobin level 
had fallen to 2.7%. At that time, Hematology was consulted 
due to continued low oxygen saturations despite lowering 
methemoglobin levels. Hematology recommended partial 
exchange transfusion with packed red blood cells and fresh 
frozen plasma. Prior to the initial exchange transfusion, 
the patient’s oxygen saturation was 85% by pulse oximetry 
while receiving supplemental oxygen via a non-rebreather 
face mask. The exchange transfusion had to be stopped as 
he developed hives on his face and chin, but more than three 
quarters of a unit of blood and a single unit of fresh frozen 
plasma was administered. The resultant oxygen saturation was 
documented in the low 90s. On the third hospital day, packed 
red blood cells were transfused without exchange, and by day 
four, his oxygen saturation had improved to 94%. The patient 
was discharged home on the fifth hospital day with stable vital 
signs (including oxygen saturation of 97%) and without end 
organ damage. The initial sulfhemoglobin level, which was 
sent on the day of the patient’s arrival, returned 10 days after 
patient’s discharge and was noted to be 10 % (0-2%). 
CASE 2
A two-year-old female accompanied the above patient. 
She also had blue-gray discoloration after drinking one 
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Table. Laboratory results for three-year-old male with cyanosis
Complete Metabolic Panel
Test Value Reference Range
Sodium 142 mmol/L 135-147 mmol/L
Potassium 3.6 mmol/L 3.5-5.5 mmol/L
Chloride 109 mmol/ L 96-108 mmol/L
Bicarbonate 22 mmol/L 22-29 mmol/L
Blood urea nitrogen 12 mg/dL 5-18 mg/dL
Creatinine 0.4 mg/dL 0.2-0.7 mg/dL
Glucose 117 mg/dL 65-99 mg/dL
Albumin 4.4 g/dL 3-5.4 g/dL
Aspartate aminotransferase 31 U/L 0-49 U/L
Alanine aminotransferase 15 U/L 0-44 U/L
Alkaline phosphatase 188 U/L 0-280 U/L
Calcium 9.8 mg/dL 8.8-10.8 mg/dL
Total bilirubin 0.5 mg/dL 0.2-1 mg/dL
Complete Blood Count
Test Value Reference Range
White blood cell  18.8 K/UL 5.5-15.5 k/µL
Hemoglobin 12.5 g/dL 10.7-14.5 g/dL
Hematocrit 36.7% 22-46%
Platelets 327 K/UL 150-450 k/µLWestern Journal of Emergency Medicine                             199                                      Volume X, n o . 3  :  August 2009
sip from the plastic water bottle and complained of similar 
abdominal pain. There was no somnolence, nausea, vomiting, 
change in behavior, or loss of consciousness. The past medical 
and family histories were unremarkable, and she was not 
taking any medications. 
The physical exam showed an oral temperature of 36.7 
degrees Celsius, heart rate 120 beats/min, respiratory rate 26 
breaths/min, capillary refill of less than 2 seconds, and oxygen 
saturation of 84% on room air by pulse oximetry. The patient’s 
weight was 15 kg. She was noted to be alert and oriented, in 
no apparent distress, speaking appropriately, with blue-gray 
central skin discoloration. The remainder of the physical exam 
was normal including clear lung sounds without stridor.
An immediate blood gas showed a pH 7.45, pCO2 28 
mmHg, pO2 233 mmHg, HCO3 19.5 mmol/L and oxygen 
saturation of 100% while the finger pulse oximeter showed an 
oxygen saturation of 92% on 100% supplemental oxygen via 
mask. Laboratory studies included a complete metabolic panel 
that was within normal limits. A complete blood count showed 
white blood cell 9.7 K/UL, hemoglobin 10 g/dL, hematocrit 
29.4%, platelets 301 K/UL. Ethanol level was <10 mg/dL, 
and a urinalysis and urine drug screen were negative. A chest 
radiograph showed no evidence of acute disease.
The same management was taken as with the previous 
patient. After the methemoglobin level was tested to be 3.8% 
with a normal carboxyhemoglobin level at 1.3%, methylene 
blue was administered at 1mg/kg without effect prior to 
admitting the patient to the pediatric ICU.
Gastroenterology performed an endoscopy showing no 
ulcers. On the second hospital day, hematology recommended 
packed red blood cell transfusion due to hemoglobin falling to 
9.1 g/dL due to presumed hemolysis from oxidant stress from 
the toxin. This improved her oxygen saturations. Exchange 
transfusion was not recommended, as she was asymptomatic. 
The patient was weaned off supplemental oxygen and 
discharged home on the sixth hospital day. 
DISCUSSION
These cases describe patients who presented with acute 
oxygen desaturation via pulse oximetry and central cyanosis 
after drinking one sip of water mixed with hydroxylamine 
sulfate, which resulted in methemoglobinemia and sulfhemo-
globinemia, a rare combination. 
Hydroxylamine sulfate is a strong acid and powerful 
reducing agent. It is a white crystalline compound containing 
nitrogen and sulfate with the formula of (NH2OH)2H2SO4 
that can cause irritation to the nose and throat, as well as 
pulmonary edema if inhaled.4 It is also corrosive and can cause 
burns to skin and, if ingested, in the mouth, esophagus and 
stomach, as was evident in one of our patients. It is known 
to cause methemoglobinemia, but sulfhemoglobinemia is 
not a stated result of exposure in the Material Safety Data 
Sheet (MSDS).5 It is usually used in photography and surface 
cleaning solutions.5 Our patient’s older sister obtained the 
product from their mother’s work, which has housecleaning 
products. It was mixed with water in a plastic bottle, was not 
labeled and easily accessible. 
As with all cases of acute oxygen desaturation, a search 
for the etiology is emergently required. After mechanical 
obstruction and cardiac shunting has been eliminated as 
a possibility, ventilation problems such as pneumothorax, 
pneumonia, or asthma and perfusion problems, such as 
pulmonary embolism, should be considered. Once these 
problems have been sufficiently ruled out, evaluation for 
abnormal blood hemoglobin is warranted.6,7 The “oxygen 
saturation gap” is the difference between the calculated 
oxygen saturation from a standard blood gas machine and 
the reading from a pulse oximeter. If it is greater than 5%, 
the patient’s hemoglobin may be abnormal, representing 
carbon monoxide poisoning, methemoglobinemia, or 
sulfhemoglobinemia. Our patients had no symptoms of 
mechanical obstruction, no history of reactive airway disease 
or cardiac abnormalities or fever, and no risk factors for 
pulmonary embolism. Their acute oxygen desaturation event 
occurred immediately after ingestion of the colorless fluid in 
the water bottle. Although the chemical was not known at the 
time, the suspicion for a toxic ingestion was high.
Methemoglobin is a product of hemoglobin in which 
the normal ferrous ion in the heme complex is converted 
by oxidation to the ferric form which does not combine 
with oxygen, but can convert back to hemoglobin by 
reducing agents such as methylene blue.7-11 Acquired 
methemoglobinemia is produced by the action of oxidants.12 
This leads to a leftward shift of the oxygen dissociation curve 
for the remaining normal hemoglobin, resulting in diminished 
oxygen unloading in the tissues and predisposing to tissue 
hypoxia.7-10 
Several enzymes work to decrease the amount of 
circulating methemoglobin molecules. Cytochrome b5 
reductase is the primary enzyme that works to decrease 
levels of oxidized hemoglobin (such as methemoglobin) by 
reducing the molecule. Other enzymes include glutathione 
peroxidase and catalase. Cellular hypoxia can occur if an 
abnormally increased oxidant stress exceeds the normal source 
of reducing power. Methylene blue is used as an electron 
donor in chemical-induced methemoglobinemia, which 
utilizes NADPH and the hexose monophosphate pathway to 
reduce methemoglobin to hemoglobin. This reduction occurs 
quickly over several minutes. The regeneration of NADPH 
requires an intact pentose phosphate pathway. It is also critical 
to remember that in those patients with glucose-6-phosphate 
dehydrogenase deficiency, methylene blue has no effect and 
can actually induce acute hemolysis.10,11
Sulfhemoglobin is a stable, green-pigmented molecule, 
which is not normally present in the body. It is made by 
the oxidation of the iron in hemoglobin to a ferric state by 
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drugs and chemicals that contain sulfur. Sulfur can bind to 
the hemoglobin molecule’s porphyrin ring, which forms 
sulfhemoglobin. Sulfhemoglobin is irreversible, lasting the 
lifetime of the erythrocyte, and sulfhemoglobin molecules 
cannot carry oxygen.3,9,12,13 Acetanilide, phenacetin, nitrates, 
trinitroluene, metoclopramide, and sulfur compounds have 
all been linked to producing sulfhemoglobinemia. The origin 
of sulfur, in cases where it is not overtly apparent, has been 
theorized to come from hydrogen sulfide released by intestinal 
organisms and/or glutathione.3,7,9,13
The concentration of sulfhemoglobin decreases as 
erythrocytes are destroyed and replaced.3 The decreased 
oxygen affinity of the unaffected hemoglobin results in 
protection of tissue oxygen delivery. Sulfhemoglobinemia 
is a rare cause of cyanosis, and patients present with mild 
to moderate clinical symptoms.3,10,13 Dyspnea is uncommon 
unless the level of sulfhemoglobin is high, although cyanosis 
can set in at much lower concentrations. It is reported that 
levels of only 0.5g/dL is sufficient for cyanosis to occur.9,10,11 
Our patients denied any symptoms consistent with end-organ 
damage (including dyspnea), but had obvious cyanosis, which 
in and of itself is not an indicator of tissue hypoxia.
Reports of physiologic affects of sulfhemoglbinemia 
display little consistency.6,9,14,15 While some describe 
sulfhemoglobin levels of 20% to 60% as benign for some 
patients, these lack evaluation of tissue oxygen status or of 
its influence on the course of patient outcome in the face of 
cardiac and pulmonary involvement.6,15 
The diagnosis of true sulfhemoglobinemia can be difficult. 
Any time there is a significant pulse oximetry desaturation 
associated with a normal arterial oxygen tension (PaO2) 
or anytime a patient remains cyanotic without response to 
methylene blue, an emergency physician should consider the 
possibility of abnormal hemoglobin species interfering with 
the pulse oximeter other than methemoglobin.3,13 Our patients 
illustrated this point clearly since there was no effect in 
oxygen saturation after methylene blue.
The knowledge of the type of co-oximeter used in the 
analysis of ABGs is also essential. Hemoximeters use multiple 
wavelengths to determine concentrations of oxyhemoglobin, 
deoxyhemoglobin, carboxyhemoglobin, and methemoglobin. 
However, different co-oximeters vary widely, with some 
not being able to distinguish between methemoglobin 
and sulfhemoglobin due to similar absorbance peaks. Gas 
chromatography is considered the “criterion” standard. 
However, to perform gas chromatography, specialized 
equipment, time and expertise are required.9,16
Some pulse oximeters use two light wavelengths 
(660nm and 940nm) to determine the ratio of pulse-added 
absorbancies. Dyshemoglobin molecules that have light 
absorbance peaks at 660nm or 940nm affect the ratio of 
light absorbancies at these wavelengths and lead to spurious 
pO2 readings. Methemoglobin has significant absorbancies 
at both wavelengths. Sulfhemoglobin molecules share a 
similar peak with methemoglobin molecules at 630nm. 
Therefore, a reported methemoglobin level may actually 
be sulfhemoglobin and be inappropriately treated with 
methylene blue as has been described in other case reports.9 
Further complicating the clinical picture, some substances 
can cause both methemoglobin and sulfhemoglobin.9,10,11 The 
blood gas analyzer at the outside institution for our case was 
able to accurately differentiate methemoglobinemia from 
sulfhemoglobinemia.
Sulfhemoglobinemia may be distinguished from 
methemoglobinemia by isoelectric focusing.4 The laboratory 
measurement of sulfhemoglobin relies on an absorption 
peak at 630nm, which, unlike methemoglobin, persists after 
the addition of cyanide or dithionate.3,7,12 Another method of 
differentiating sulfhemoglobin from methemoglobin involves 
carbon monoxide, since it binds to sulfhemoglobin but not 
to methemoglobin. Finally, newer generation co-oximeters 
that are designed to assess sulfhemoglobin and other types 
of hemoglobin can differentiate between the two types.9,17,18 
The sulfhemoglobin level in our case returned 10 days after 
initially sent and was analyzed in an outside laboratory using 
potassium cyanide.
There is no specific treatment for sulfhemoglobinemia. 
Most treatment recommendations for sulfhemoglobinemia 
state to remove the offending agent, and with low levels 
of sulfhemoglobin, no more than observation is needed, 
usually until they are clinically stable and it is clear that the 
cyanosis and/or sulfhemoglobin level is improving.3,6,9,11,15 
Lim and Lower19 suggest exchange transfusion as a means of 
managing extreme sulfhemoglobinemia. Other sources state 
that exchange transfusion is hardly justified, since the cyanosis 
itself is in no way disabling.12 Exchange transfusion and 
packed red blood cell transfusion improved oxygen saturations 
in our patients, reversed the cyanosis, and maintained normal 
oxygen saturation through the rest of their hospital stay. In 
retrospect, these interventions may not have been necessary 
in our patients, since low levels sulfhemoglobin will cause 
little if any effect. Also, exchange shares similar risks as other 
blood transfusion products.
CONCLUSION
Hydroxylamine sulfate, a strong acid known to cause 
methemoglobinemia but not sulfhemoglobinemia, was 
mixed in a water bottle and not appropriately labeled. The 
hydroxylamine sulfate was ingested by two children causing 
a mixed methemoglobinemia and sulfhemoglobinemia. 
Sulfhemoglobinemia itself is rare, difficult to distinguish 
from methemoglobinemia, and (at high levels) can result in 
end-organ damage. Our patients did not respond to methylene 
blue treatment, illustrating that their oxygen desaturation was 
mainly due to sulfhemoglobinemia. Sulfhemoglobinemia may 
appear identical to methemoglobinemia by co-oximeters that 
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cannot differentiate between the two molecules. Knowledge 
of the co-oximeter used at your institution can help to 
differentiate the abnormal hemoglobin molecules. Exchange 
transfusion and packed red blood cell transfusion immediately 
increased our patients’ oxygen saturations, which may have 
prevented end-organ damage, illustrating the importance of 
early recognition and intervention. However, given the low 
levels of sulfhemoglobin, observation alone may have been 
sufficient.
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